Center for Drug Design Researchers Receive University Innovation Impact Case Award
April 29, 2022
MINNEAPOLIS
Apr. 29, 2022
The Center for Drug Design’s Dr. Swati More and Dr. Robert Vince are recipients of an Innovation Impact Case Award. These inaugural awards are presented by the Office of the Vice President for Research (OVPR) to recognize University of Minnesota research that has led to significant impact outside of academia.
“The Innovation Impact Case Award is the most prestigious award from the Office of the Vice President for Research. It shines a light on remarkable research across all disciplines that is solving important problems and benefiting society in a meaningful way,” says interim vice president for research, Michael Oakes.
The profoundly impactful work of Drs. Swati and Vince being recognized for this distinguished award is research that resulted in the development of a noninvasive, scalable tool for Alzheimer’s detection using the retina of the eye, without use of any extraneous dyes.
Read more about the journey of this research and what’s next.
Media Contacts
Related Stories
Dr. Melanie Nicol, associate professor and director of graduate studies in the Department of Experimental and Clinical Pharmacology (ECP) received a new award of $3 million across the next five years from the National Institutes of Health (NIH).
Duerfeldt's research is focused on the development of chemical tools that can be utilized to enhance our understanding of disease mechanisms and the development of new therapeutic leads for bacterial infections and ocular diseases.
Assistant professor Ameya Kirtane, PhD, has joined the College of Pharmacy’s Department of Pharmaceutics.